Clinical Trial Update: Raltegravir Activity In Lymphoid Tissues [NA]

View source ↗

Summary

The clinical trial evaluating raltegravir activity in lymphoid tissues for HIV infection has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Raltegravir (raltegravir)

Snippet

Sponsor: University of Minnesota | Conditions: HIV Infection, HIV Infections | NA | Status: WITHDRAWN